E07-001: Safety and Efficacy Extension Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
Clinical trial NCT01194804 · COMPLETED
Trial details
- NCT number
- NCT01194804
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-09-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.